Red Sox ace Garrett Crochet suffers a setback, won't face live hitters on Tuesday as ...

Sympathisers, friends, neighbours and relatives have besieged the residence of the slain technician, Mr Idris Abiodun Clement, in the Shagari area of Akure, the Ondo State capital, to mourn his ...

Shohei Ohtani hit his 300th career homer but two errors by the Los Angeles Dodgers in the eighth inning led to three runs by the Colorado Rockies, who rallied for a 4-3 victory Tuesday night. Shohei ...

“I think it’s over,” President Trump said, referring to the preliminary truce. Iran’s armed forces earlier said they had targeted U.S. military sites in Bahrain and Kuwait in response to the latest ...

Vertex to buy Crinetics for $10 billion in rare-diseases push Vertex Pharmaceuticals will buy Crinetics Pharmaceuticals for a total equity value of about $10 billion, the companies said on Monday, ...

As a coauthor of this column for a number of years now, I have covered the topic of disability insurance in the past. As all orthopedists know, in theory at least, disability can happen to any of us, ...

Yahoo Sports TVyahoosports.tv is here! Watch live shows and highlights 24/7. The Kevin O'Connor ShowKevin O'Connor talks ball with the best names from around the world of basketball. The Ariel Helwani ...

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

May 29, 2026 A new study suggests Antarctica’s ice sheet hit a climate tipping point about one million years ago, making it far more reactive to temperature and CO2 changes. Researchers warn this ...

Genetics is the branch of science concerned with genes, heredity, and variation in living organisms. It seeks to understand the process of trait inheritance from parents to offspring, including the ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...